Amyloidosis Center News

ISA 2024 Report

Click here to view a synopsis of the BU Amyloidosis Center's attendance at the International Symposium on Amyloidosis at the Mayo Clinic May 26-30, 2024.

How Well Are You Managing Transthyretin Amyloidosis (ATTR)?

https://url.us.m.mimecastprotect.com/s/CIYtCzp59jCkoYkKh4FCbx?domain=everydayhealth.com/ An article for Everyday Health about managing transthyretin amyloidosis, lifestyle habits, treatment, medication, and complications with our very own Lisa Mendelson, NP. 

2024 Webinar: ATTR Cardiac Amyloidosis

What's new and exciting in ATTR cardiac amyloidosis in 2024 Dr. Fredrick Ruberg and Dr. Omar Siddiqi discuss the general overview of ATTR treatment with new developments over the past year (APOLLO-B, ATTRibute-CM), currently enrolled trials (HELIOS-B, CARDIOTTRansform), and future trials (DepleTTR-CM, MAGNITUDE). They will also cover current heart failure therapy... More

17th Annual Bill’s Race to Beat Amyloid at Cannon

Our anonymous matching grant donor has raised the challenge to $7500 for 2024! Race & Silent Auction - Saturday, March 9th at 11 a.m. 17th Annual Bill’s Race to Beat Amyloid at Cannon March 1, 2023 - March 31, 2023 Register to race & be eligible to buy an all-mountain ticket for $55 Complete... More

Alexis Doria Receives Department of Medicine STAR Employee Recognition Award!

Congratulations to Alexis Doria, administrative manager of the Amyloidosis Center for receiving a Department of Medicine STAR Employee Recognition Award!  The “STARDoM” program, sponsored by the Boston University Department of Medicine, seeks to recognize outstanding non-physician employees who work in all areas, including administration, clinical care and research.

Dr. Frederick Ruberg Promoted to Professor of Medicine at Boston University

Frederick Ruberg, MD, Medicine/Cardiovascular Medicine and Radiology, is associate chief for cardiovascular medicine at Boston Medical Center (BMC) and a clinical scientist with expertise in cardiac amyloidosis with continuous funding since 2005. He senior authored a number of important consensus guidelines statements relative to cardiac imaging, cardiac amyloidosis management and... More